PURPOSE: Total pancreatectomy (TP) eliminates the risk and morbidity of pancreatic leak after pancreaticoduodenectomy (PD). However, TP is a more extensive procedure with guaranteed endocrine and exocrine insufficiency. Previous studies conflict on the net benefit of TP. METHODOLOGY: A comparison of patients undergoing non-emergent, curative-intent TP or PD for pancreatic neoplasia using the National Surgical Quality Improvement Project data from 2005-2011 was done. Main outcome measures were mortality and major and minor morbidities. RESULTS: Of the 6,314 (97%) who underwent PD and the 198 (3%) who underwent TP, malignancy was present in 84% of patients. The two groups were comparable at baseline. Mortality was higher after TP (6.1%) than DP (3.1%), p = 0.02. Adjusting for differences on multivariable analysis, TP carried increased mortality (OR 2.64, 95% CI 1.3-5.2, p = 0.005). TP was also associated with increased rates of major morbidity (38 vs. 30%, p = 0.02) and blood transfusion (16 vs. 10%, p = 0.01). Infectious and septic complications occurred equally in both groups. CONCLUSION: The morbidity of a pancreatic fistula can be eliminated by TP. However, based on our findings, TP is associated with increased major morbidity and mortality. TP cannot be routinely recommended for to reduce perioperative morbidity when pancreaticoduodenectomy is an appropriate surgical option.
PURPOSE: Total pancreatectomy (TP) eliminates the risk and morbidity of pancreatic leak after pancreaticoduodenectomy (PD). However, TP is a more extensive procedure with guaranteed endocrine and exocrine insufficiency. Previous studies conflict on the net benefit of TP. METHODOLOGY: A comparison of patients undergoing non-emergent, curative-intent TP or PD for pancreatic neoplasia using the National Surgical Quality Improvement Project data from 2005-2011 was done. Main outcome measures were mortality and major and minor morbidities. RESULTS: Of the 6,314 (97%) who underwent PD and the 198 (3%) who underwent TP, malignancy was present in 84% of patients. The two groups were comparable at baseline. Mortality was higher after TP (6.1%) than DP (3.1%), p = 0.02. Adjusting for differences on multivariable analysis, TP carried increased mortality (OR 2.64, 95% CI 1.3-5.2, p = 0.005). TP was also associated with increased rates of major morbidity (38 vs. 30%, p = 0.02) and blood transfusion (16 vs. 10%, p = 0.01). Infectious and septic complications occurred equally in both groups. CONCLUSION: The morbidity of a pancreatic fistula can be eliminated by TP. However, based on our findings, TP is associated with increased major morbidity and mortality. TP cannot be routinely recommended for to reduce perioperative morbidity when pancreaticoduodenectomy is an appropriate surgical option.
Authors: Sushanth Reddy; Christopher L Wolfgang; John L Cameron; Frederic Eckhauser; Michael A Choti; Richard D Schulick; Barish H Edil; Timothy M Pawlik Journal: Ann Surg Date: 2009-08 Impact factor: 12.969
Authors: Brian J Billings; John D Christein; William S Harmsen; Jeffrey R Harrington; Suresh T Chari; Florencia G Que; Michael B Farnell; David M Nagorney; Michael G Sarr Journal: J Gastrointest Surg Date: 2005-11 Impact factor: 3.452
Authors: C Max Schmidt; Jeffrey Glant; Jordan M Winter; Jason Kennard; Jennifer Dixon; Qianqian Zhao; Thomas J Howard; James A Madura; Atilla Nakeeb; Henry A Pitt; John L Cameron; Charles J Yeo; Keith D Lillemoe Journal: Surgery Date: 2007-10 Impact factor: 3.982
Authors: Srinevas K Reddy; Timothy M Pawlik; Daria Zorzi; Ana L Gleisner; Dario Ribero; Lia Assumpcao; Andrew S Barbas; Eddie K Abdalla; Michael A Choti; Jean-Nicolas Vauthey; Kirk A Ludwig; Christopher R Mantyh; Michael A Morse; Bryan M Clary Journal: Ann Surg Oncol Date: 2007-09-01 Impact factor: 5.344
Authors: James T McPhee; Joshua S Hill; Giles F Whalen; Maksim Zayaruzny; Demetrius E Litwin; Mary E Sullivan; Frederick A Anderson; Jennifer F Tseng Journal: Ann Surg Date: 2007-08 Impact factor: 12.969
Authors: C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt Journal: Ann Surg Date: 1995-06 Impact factor: 12.969
Authors: Hari Nathan; Christopher L Wolfgang; Barish H Edil; Michael A Choti; Joseph M Herman; Richard D Schulick; John L Cameron; Timothy M Pawlik Journal: J Surg Oncol Date: 2009-02-01 Impact factor: 3.454
Authors: Mehrdad Nikfarjam; Mandeep Sehmbey; Eric T Kimchi; Niraj J Gusani; Serene Shereef; Diego M Avella; Kevin F Staveley-O'Carroll Journal: J Gastrointest Surg Date: 2009-02-07 Impact factor: 3.452
Authors: Riccardo Casadei; Claudio Ricci; Giovanni Taffurelli; Anna Guariniello; Anthony Di Gioia; Mariacristina Di Marco; Nico Pagano; Carla Serra; Lucia Calculli; Donatella Santini; Francesco Minni Journal: J Gastrointest Surg Date: 2016-07-14 Impact factor: 3.452
Authors: José M Alamo; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Lydia Barrera; Miguel A Gómez; Jordi Muntané; Francisco J Padillo Journal: World J Gastroenterol Date: 2014-10-21 Impact factor: 5.742
Authors: Amer H Zureikat; Trang Nguyen; Brian A Boone; Martin Wijkstrom; Melissa E Hogg; Abhinav Humar; Herbert Zeh Journal: Surg Endosc Date: 2014-07-09 Impact factor: 4.584
Authors: Michael R Driedger; Carlos A Puig; Cornelius A Thiels; John R Bergquist; Daniel S Ubl; Elizabeth B Habermann; Travis E Grotz; Rory L Smoot; David M Nagorney; Sean P Cleary; Michael L Kendrick; Mark J Truty Journal: BMC Surg Date: 2020-07-27 Impact factor: 2.102